Effect of Ethanol Extract from Kersen Leaves (Muntingia calabura L.) on Changes in Blood Factors Total Cholesterol, Triglycerides, LDL and HDL in Hyperlipidemia Mice
{"title":"Effect of Ethanol Extract from Kersen Leaves (Muntingia calabura L.) on Changes in Blood Factors Total Cholesterol, Triglycerides, LDL and HDL in Hyperlipidemia Mice","authors":"Tridiganita Intan Solikhah, Gahastanira Permata Solikhah","doi":"10.52711/0974-360x.2024.00112","DOIUrl":null,"url":null,"abstract":"Hyperlipidemia is a risk factor of cardiovascular disorder in diabetes mellitus. Lack of insulin in diabetes mellitus can increase lipolysis which leads to an increased free fatty acid that also increases total cholesterol level and LDL (Low-Density Lipoprotein). This study aims to determine the effect of Muntingia calabura leaf extract on the level of total cholesterol (TC), triglycerides (TG), LDL, and High Density Lipoproteins (HDL) of alloxan-induced male white mice. Thirty male mice were separated into five groups: negative control (NC) without alloxan and extract, diabetes control (DC) with only alloxan, treatment 1 (T1) with alloxan and 100mg/kgBW of M. calabura leaf extract, treatment 2 (T2) with alloxan and 300 mg/kgBW of M. calabura leaves extract, and positive control (PC) with alloxan and 600 µg/kgBW of glibenclamide. One-Way Anova demonstrated that the administration of glibenclamide and M. calabura effectively reduce TC, TG, LDL and increase HDL compared to the diabetes control group (P<0.05) and the most effective dose M. calabura to decrease TC, TG, LDL, and to increase HDL were 300 mg/kgBW. Extraction using 96% ethanol of M. calabura leaf affects the reduction of TC, TG, LDL, and the increase of HDL in the blood and it can be developed as alternative of antihyperlipidemia drugs.","PeriodicalId":21141,"journal":{"name":"Research Journal of Pharmacy and Technology","volume":"740 ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research Journal of Pharmacy and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52711/0974-360x.2024.00112","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
Hyperlipidemia is a risk factor of cardiovascular disorder in diabetes mellitus. Lack of insulin in diabetes mellitus can increase lipolysis which leads to an increased free fatty acid that also increases total cholesterol level and LDL (Low-Density Lipoprotein). This study aims to determine the effect of Muntingia calabura leaf extract on the level of total cholesterol (TC), triglycerides (TG), LDL, and High Density Lipoproteins (HDL) of alloxan-induced male white mice. Thirty male mice were separated into five groups: negative control (NC) without alloxan and extract, diabetes control (DC) with only alloxan, treatment 1 (T1) with alloxan and 100mg/kgBW of M. calabura leaf extract, treatment 2 (T2) with alloxan and 300 mg/kgBW of M. calabura leaves extract, and positive control (PC) with alloxan and 600 µg/kgBW of glibenclamide. One-Way Anova demonstrated that the administration of glibenclamide and M. calabura effectively reduce TC, TG, LDL and increase HDL compared to the diabetes control group (P<0.05) and the most effective dose M. calabura to decrease TC, TG, LDL, and to increase HDL were 300 mg/kgBW. Extraction using 96% ethanol of M. calabura leaf affects the reduction of TC, TG, LDL, and the increase of HDL in the blood and it can be developed as alternative of antihyperlipidemia drugs.
期刊介绍:
Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal, devoted to pharmaceutical sciences. The aim of RJPT is to increase the impact of pharmaceutical research both in academia and industry, with strong emphasis on quality and originality. RJPT publishes Original Research Articles, Short Communications, Review Articles in all areas of pharmaceutical sciences from the discovery of a drug up to clinical evaluation. Topics covered are: Pharmaceutics and Pharmacokinetics; Pharmaceutical chemistry including medicinal and analytical chemistry; Pharmacognosy including herbal products standardization and Phytochemistry; Pharmacology: Allied sciences including drug regulatory affairs, Pharmaceutical Marketing, Pharmaceutical Microbiology, Pharmaceutical biochemistry, Pharmaceutical Education and Hospital Pharmacy.